Literature DB >> 2188699

Pelvic inflammatory disease.

J M Pearce1.   

Abstract

Mesh：

Substances：

Year:  1990        PMID： 2188699      PMCID： PMC1662796          DOI： 10.1136/bmj.300.6732.1090

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  23 in total

1.  Effect of acute pelvic inflammatory disease on fertility.

Authors:  L Weström
Journal:  Am J Obstet Gynecol       Date:  1975-03-01       Impact factor: 8.661

2.  T mycoplasmas on spermatozoa and infertility.

Authors:  H Gnarpe; J Friberg
Journal:  Nature       Date:  1973-09-14       Impact factor: 49.962

3.  Laparoscopy in evaluation of pelvic pain.

Authors:  W I Lundberg; J E Wall; J E Mathers
Journal:  Obstet Gynecol       Date:  1973-12       Impact factor: 7.661

4.  Objectivized diagnosis of acute pelvic inflammatory disease. Diagnostic and prognostic value of routine laparoscopy.

Authors:  L Jacobson; L Weström
Journal:  Am J Obstet Gynecol       Date:  1969-12-01       Impact factor: 8.661

5.  Measurement of intra-vaginal and intra-uterine pressures during human coitus by radio-telemetry.

Authors:  C A Fox; H S Wolff; J A Baker
Journal:  J Reprod Fertil       Date:  1970-07

6.  Effect of the venereal diseases epidemic on the incidence of ectopic pregnancy -- implications for the evaluation of contraceptives.

Authors:  J Urquhart
Journal:  Contraception       Date:  1979-05       Impact factor: 3.375

7.  The intrauterine device: a bacteriologic study of the endometrial cavity.

Authors:  D R Mishell; J H Bell; R G Good; D L Moyer
Journal:  Am J Obstet Gynecol       Date:  1966-09-01       Impact factor: 8.661

8.  Gonorrhea screening in male consorts of women with pelvic infection.

Authors:  L C Gilstrap; W N Herbert; F G Cunningham; J C Hauth; H G Van Patten
Journal:  JAMA       Date:  1977-08-29       Impact factor: 56.272

9.  Use of laparoscopy to determine the microbiologic etiology of acute salpingitis.

Authors:  R L Sweet; J Mills; K W Hadley; E Blumenstock; J Schachter; M O Robbie; D L Draper
Journal:  Am J Obstet Gynecol       Date:  1979-05-01       Impact factor: 8.661

10.  Chilamydia trachomatis infection in patients with acute salpingitis.

Authors:  P A Mårdh; T Ripa; L Svensson; L Weström
Journal:  N Engl J Med       Date:  1977-06-16       Impact factor: 91.245
View more
  9 in total

Review 1.  Pelvic inflammatory disease epidemiology: what do we know and what do we need to know?

Authors:  I Simms; J M Stephenson
Journal:  Sex Transm Infect       Date:  2000-04       Impact factor: 3.519

2.  Risk factors for laparoscopically confirmed pelvic inflammatory disease: findings from Mumbai (Bombay), India.

Authors:  A Gogate; L Brabin; S Nicholas; S Gogate; T Gaonkar; A Naidu; A Divekar; A Karande; C A Hart
Journal:  Sex Transm Infect       Date:  1998-12       Impact factor: 3.519

3.  Non-specific abdominal pain: the resource implications.

Authors:  S Paterson-Brown; J N Thompson
Journal:  Ann R Coll Surg Engl       Date:  1992-09       Impact factor: 1.891

Review 4.  Gynaecological infections and strategies for treatment.

Authors:  A J Roex
Journal:  Pharm Weekbl Sci       Date:  1990-12-14

Review 5.  Bacterial challenges and evolving antibacterial drug strategy.

Authors:  B Watt; J G Collee
Journal:  Postgrad Med J       Date:  1992-01       Impact factor: 2.401

6.  Pelvic inflammatory disease.

Authors: 
Journal:  BMJ       Date:  1990-05-26

7.  How well is pelvic inflammatory disease managed in general practice? A postal questionnaire survey.

Authors:  M Huengsberg; C B Ip; K W Radcliffe
Journal:  Sex Transm Infect       Date:  1998-10       Impact factor: 3.519

8.  Study of usage pattern of nonsteroidal anti-inflammatory drugs (NSAIDs) among different practice categories in Indian clinical setting.

Authors:  A D Paul; C K Chauhan
Journal:  Eur J Clin Pharmacol       Date:  2004-12-17       Impact factor: 2.953

Review 9.  General practice update: chlamydia infection in women.

Authors:  P Oakeshott; P Hay
Journal:  Br J Gen Pract       Date:  1995-11       Impact factor: 5.386
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.